# US 2012/0252887 A1 · Composition and method for treating diabetes and metabolic disorders

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0252887 A1
- Document ID: US20120252887A1
- Status: Published application
- Kind: A1
- Application number: 13/492,986
- Filed: 2012-06-11
- Published: 2012-10-04
- Earliest claimed: 2007-03-19
- Assignees: Atm Metabolics Lllp
- Inventors: Milton Joseph Ahrens; Daryl Lee Thompson
- Web page: https://patentgrep.com/patent/US20120252887A1

## CPC

- A61K 31/352: condensed with carbocyclic rings, e.g. methantheline {(cannabinoids A61K31/658)}
- A21D 2/14: Organic oxygen compounds
- A21D 2/36: Vegetable material
- A23L 2/02: containing fruit or vegetable juices
- A23L 2/04: Extraction of juices (machines or apparatus for extracting juice A23N1/00, A47J19/00)
- A23L 5/00: Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L 7/126: Snacks or the like obtained by binding, shaping or compacting together cereal grains or cereal pieces, e.g. cereal bars
- A23L 27/30: Artificial sweetening agents
- A23L 29/30: containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin (products from apiculture A23L21/20; artificial sweetening agents A23L27/30)
- A23L 33/10: using additives (addition of substantially indigestible substances A23L33/21)
- A23L 33/105: Plant extracts, their artificial duplicates or their derivatives
- A23L 33/125: containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates (indigestible substances A23L33/21)
- A23L 33/40: {Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula}
- A61K 31/192: having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid {(cannabinoids A61K31/658)}
- A61K 31/216: of acids having aromatic rings, e.g. benactizyne, clofibrate
- A61K 31/353: 3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61P 3/04: Anorexiants; Antiobesity agents
- A61P 3/10: for hyperglycaemia, e.g. antidiabetics
- A23L 7/00: Cereal-derived products; Malt products; Preparation or treatment thereof (preparation of malt for brewing C12C)
- A23V 2002/00: Food compositions, function of food ingredients or processes for food or foodstuffs
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A21D: TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS (preservation of flour or dough before baking A23B40/00; preservation of bakery products A23B45/00)
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A23V: INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION

## Abstract

A composition and method for treating diabetes and metabolic disorders, and for achieving weight loss in a subject comprising a combination of naturally occurring compounds is provided.

## Claims

### Claim 1

A composition for treating diabetes or obesity consisting essentially of therapeutically effective amounts quercetin, myricetin and chlorogenic acid.

### Claim 2 (depends on 1)

The composition of claim 1, wherein about 5 to about 100 mg quercetin; about 100 to about 500 mg chlorogenic acid; and about 100 to about 500 mg myricetin are present in the composition.

### Claim 3 (depends on 1)

The composition of claim 1, wherein about 5 to about 50 mg quercetin; about 250 to about 400 mg chlorogenic acid; and about 250 to about 400 mg myricetin are present in the composition.

### Claim 4 (depends on 1)

The composition of claim 1 wherein the ratio of quercetin to chlorogenic acid to myricetin of is about 1:(40-55):(40-55).

### Claim 5 (depends on 1)

A pharmaceutical composition consisting of a pharmaceutically acceptable carrier in combination with the composition of claim 1.

### Claim 6 (depends on 1)

A dietary supplement consisting of a consumable carrier in combination with the composition of claim 1.

### Claim 7 (depends on 1)

A foodstuff additive consisting of the composition of claim 1.

### Claim 8

A dietary supplement for lowering the glycemic index of a carbohydrate-containing foodstuff consisting essentially of an effective amount of quercetin, myricetin and chlorogenic acid.

### Claim 9 (depends on 8)

The dietary supplement of claim 8 wherein about 5 to about 100 mg quercetin; about 100 to about 500 mg chlorogenic acid; and about 100 to about 500 mg myricetin are present in the dietary supplement.

### Claim 10 (depends on 8)

The dietary supplement of claim 8 wherein about 5 to about 50 mg quercetin; about 250 to about 400 mg chlorogenic acid; and about 250 to about 400 mg myricetin are present in the dietary supplement.
